SPRING Vision Announces Investment from MediPress Health Limited Partnership
Summary
HAIFAIsrael , July 5, 2022 /PRNewswire/ SPRING Vision, develops non-invasive real-time multispectral retinal imaging technology for automated diagnosis of ocular and systemic diseases, announces investment of MediPressa public R&D Life Science limited partnership (TASE: MPRS) which invests in medical R&D companies specializing in digital and advanced technologies.Noam AllonCEO of SPRING Vision: We are proud to have been chosen by MediPress, a professional and selective fund, led by highly experienced medical executives. According to Prof. Joseph PressChairman and CEO of MediPress Health, SPRING Vision is an example of the companies we want to invest in breakthrough technology, products that will impact both clinicians and patients, and a highly experienced management team. Several clinical trials will begin in the UNITED STATES and Israel within a few weeks, in addition to an ongoing clinical trial in India.Future releases of this product and other products under development will include new features, with vast market potential: early detection of retinal diseases, which can save patients eyesight and reduce the number of unnecessary surgeries; through tissue oximetry which, for the first time, will refer to the level of tissue oxygenation at different depth levels, rather than to the oximetry of large blood vessels; and microangiography capillary blood vessels; to prediction of systemic diseaseswhich will be enabled by state-of-the-art AI tools and a self-operating autonomous device, dramatically reducing mortality rates and with an immediate positive impact on the annual expenditures of healthcare organizations.About SPRING VisionSPRING Vision was founded in 2013 through an exclusive IP license by Sheba Medical Center, Israelwith the leading participation of the famous Prof. Michael Belkin & Prof. Arie Orenstein. Led by CEO Noam Allonwho brings 35 years of experience leading medical imaging businesses, the Company offers a unique combination of cutting-edge technology and medical devices that together generate invaluable insights.The human retina is a map of crucial information about bodily health conditions, and SPRING Vision uses it to collect vital data. Powered by proprietary Multispectral Imaging (MSI) technology, which has 7 patent families, the companys products describe a journey through the retina enabling microangiography, all with the click of a button.